These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34799634)

  • 1. Cuprizone feed formulation influences the extent of demyelinating disease pathology.
    Toomey LM; Papini M; Lins B; Wright AJ; Warnock A; McGonigle T; Hellewell SC; Bartlett CA; Anyaegbu C; Fitzgerald M
    Sci Rep; 2021 Nov; 11(1):22594. PubMed ID: 34799634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia.
    Nomura T; Bando Y; You H; Tanaka T; Yoshida S
    Neurochem Res; 2017 Dec; 42(12):3525-3536. PubMed ID: 28929408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.
    Esser S; Göpfrich L; Bihler K; Kress E; Nyamoya S; Tauber SC; Clarner T; Stope MB; Pufe T; Kipp M; Brandenburg LO
    Mol Neurobiol; 2018 Aug; 55(8):6237-6249. PubMed ID: 29288338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocyte ablation induced by La-aminoadipate (L-AAA) potentiates remyelination in a cuprizone demyelinating mouse model.
    Madadi S; Pasbakhsh P; Tahmasebi F; Mortezaee K; Khanehzad M; Boroujeni FB; Noorzehi G; Kashani IR
    Metab Brain Dis; 2019 Apr; 34(2):593-603. PubMed ID: 30652255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional differences between grey and white matter in cuprizone induced demyelination.
    Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
    Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a combination of ion channel inhibitors on pathology in a model of demyelinating disease.
    Gopalasingam G; Bartlett CA; McGonigle T; Majimbi M; Warnock A; Ford A; Gough A; Toomey LM; Fitzgerald M
    Mult Scler Relat Disord; 2019 Sep; 34():1-8. PubMed ID: 31202958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination.
    Wu Y; Dong L; Huang Q; Sun L; Liao Y; Tang Y; Wu Y
    Life Sci; 2019 Sep; 232():116501. PubMed ID: 31163175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of minocycline on cuprizone induced cortical demyelination.
    Skripuletz T; Miller E; Moharregh-Khiabani D; Blank A; Pul R; Gudi V; Trebst C; Stangel M
    Neurochem Res; 2010 Sep; 35(9):1422-33. PubMed ID: 20544279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.
    Hiremath MM; Saito Y; Knapp GW; Ting JP; Suzuki K; Matsushima GK
    J Neuroimmunol; 1998 Dec; 92(1-2):38-49. PubMed ID: 9916878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
    Steelman AJ; Thompson JP; Li J
    Neurosci Res; 2012 Jan; 72(1):32-42. PubMed ID: 22015947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.
    Binder MD; Cate HS; Prieto AL; Kemper D; Butzkueven H; Gresle MM; Cipriani T; Jokubaitis VG; Carmeliet P; Kilpatrick TJ
    J Neurosci; 2008 May; 28(20):5195-206. PubMed ID: 18480276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis.
    Kipp M; Norkus A; Krauspe B; Clarner T; Berger K; van der Valk P; Amor S; Beyer C
    Inflamm Res; 2011 Aug; 60(8):723-6. PubMed ID: 21516513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of ellagic acid on cuprizone-induced acute demyelination through limitation of microgliosis, adjustment of CXCL12/IL-17/IL-11 axis and restriction of mature oligodendrocytes apoptosis.
    Sanadgol N; Golab F; Tashakkor Z; Taki N; Moradi Kouchi S; Mostafaie A; Mehdizadeh M; Abdollahi M; Taghizadeh G; Sharifzadeh M
    Pharm Biol; 2017 Dec; 55(1):1679-1687. PubMed ID: 28447514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
    Acs P; Komoly S
    Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 Mice.
    Hochstrasser T; Exner GL; Nyamoya S; Schmitz C; Kipp M
    J Mol Neurosci; 2017 Apr; 61(4):617-624. PubMed ID: 28238065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednisone alleviates demyelination through regulation of the NLRP3 inflammasome in a C57BL/6 mouse model of cuprizone-induced demyelination.
    Yu H; Wu M; Lu G; Cao T; Chen N; Zhang Y; Jiang Z; Fan H; Yao R
    Brain Res; 2018 Jan; 1678():75-84. PubMed ID: 29038005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cuprizone model: regional heterogeneity of pathology.
    Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
    APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.
    El-Etr M; Rame M; Boucher C; Ghoumari AM; Kumar N; Liere P; Pianos A; Schumacher M; Sitruk-Ware R
    Glia; 2015 Jan; 63(1):104-17. PubMed ID: 25092805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of oligomeric proanthocyanidin in cuprizone-induced demyelination.
    Wang Q; Wang J; Yang Z; Sui R; Miao Q; Li Y; Yu J; Liu C; Zhang G; Xiao B; Ma C
    Exp Physiol; 2019 Jun; 104(6):876-886. PubMed ID: 30811744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.